Tivic Health Systems, Inc.

TIVC Nasdaq CIK: 0001787740

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 1305 E. HOUSTON STREET, SAN ANTONIO, TX,
Mailing Address 1305 E. HOUSTON STREET, SAN ANTONIO, TX,
Phone (888)276-6888
Fiscal Year End 1231
EIN 814016391

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 30, 2026 View on SEC
8-K Current report of material events March 25, 2026 View on SEC
8-K Current report of material events March 20, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
8-K Current report of material events March 13, 2026 View on SEC
8-K Current report of material events March 11, 2026 View on SEC
8-K Current report of material events March 4, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 27, 2026 View on SEC
8-K/A Current report amendment February 23, 2026 View on SEC
4 Insider stock transaction report February 20, 2026 View on SEC

Annual Reports

10-K March 30, 2026
  • Strategic pivot from consumer health gadgets to early-stage biotech drug development.
  • Exclusive partnership with Statera Biopharma to develop treatments for conditions like Acute Radiation Syndrome.
View Analysis

Material Events

8-K Financial Distress March 25, 2026
High Impact
  • Company transitioning to a liquidating trust to dissolve operations
  • Cessation of all research, marketing, and customer support activities
View Analysis
8-K Financial Distress March 20, 2026
High Impact
  • Tivic Health is a commercial-stage health technology company creating bioelectronic medicine.
  • Their main product, ClearUP, is FDA-cleared.
View Analysis
8-K Leadership Change March 4, 2026
High Impact
  • New CEO Michael K. Handley brings over 30 years of life sciences experience, with a strong track record in drug and device commercialization, regulatory affairs, and strategic deals.
  • Potential for accelerated market penetration and optimized sales for Tivic Health's flagship product, ClearUP® Sinus Pain Relief.
View Analysis

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.